Drreddys Laboratories | RDY - Ebitda


Drreddys Laboratories reported INR8.63B in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
ANI Pharmaceuticals USD 65.36M 5.76M Dec/2025
Aurora Cannabis CAD 3.7M 14.78M Mar/2026
Bayer EUR 2.14B 2.31B Jun/2026
Canopy Growth CAD -137M 134.13M Mar/2026
Cipla INR 14.03B 4.48B Jun/2026
Corcept Therapeutics USD -49M 53.2M Mar/2026
Drreddys Laboratories INR 8.63B 12.96B Mar/2026
GlaxoSmithKline GBP 3.51B 734M Jun/2026
Hikma Pharmaceutical USD 369M 84M Dec/2024
Lonza CHF 1.01B 54M Dec/2025
Novartis USD 6.48B 1.19B Jun/2026
Pacira USD 48.67M 8.43M Jun/2026
Phibro Animal Health USD 68.1M 6.2M Dec/2025
Prestige Brands USD 90.82M 3.99M Dec/2025
Richter Gedeon HUF 83.47B 692M Mar/2026
Sun Pharmaceuticals INR 44.18B 4.63B Jun/2026
Supernus Pharmaceuticals USD 31.6M 2.37M Jun/2026
Teva Pharmaceutical Industries USD 474M 581M Jun/2026